Enhabit, Inc. (NYSE:EHAB) Shares Bought by Stoneridge Investment Partners LLC

Stoneridge Investment Partners LLC lifted its position in shares of Enhabit, Inc. (NYSE:EHAB) by 22.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,533 shares of the company’s stock after buying an additional 2,308 shares during the period. Stoneridge Investment Partners LLC’s holdings in Enhabit were worth $98,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Franklin Resources Inc. increased its stake in Enhabit by 19.6% during the third quarter. Franklin Resources Inc. now owns 32,382 shares of the company’s stock worth $256,000 after acquiring an additional 5,317 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in Enhabit by 37.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock valued at $2,411,000 after buying an additional 83,707 shares during the period. Systematic Financial Management LP lifted its position in Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after buying an additional 199,235 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in Enhabit during the third quarter worth about $215,000. Finally, XTX Topco Ltd acquired a new stake in shares of Enhabit during the third quarter valued at about $123,000.

Insider Activity at Enhabit

In other news, Director Jeffrey Bolton bought 4,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the completion of the purchase, the director now owns 98,144 shares of the company’s stock, valued at approximately $852,871.36. This represents a 4.25 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stuart M. Mcguigan purchased 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was purchased at an average price of $8.81 per share, with a total value of $132,150.00. Following the purchase, the director now directly owns 46,810 shares of the company’s stock, valued at $412,396.10. The trade was a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on EHAB. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and upped their price objective for the stock from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners restated a “market perform” rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $8.75.

Enhabit Trading Up 0.8 %

NYSE EHAB opened at $8.31 on Friday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market cap of $417.86 million, a price-to-earnings ratio of -3.58 and a beta of 1.83. The firm has a 50 day simple moving average of $8.06 and a 200-day simple moving average of $8.03. Enhabit, Inc. has a one year low of $6.85 and a one year high of $11.74.

Enhabit (NYSE:EHAB) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million during the quarter, compared to analysts’ expectations of $261.69 million. During the same period in the prior year, the business earned $0.03 EPS. Equities research analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.